title: Soaring ADAP costs continue to force restrictions in access.
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000191:economics*; D016527:Drug Costs; D005102:Health Expenditures; D006297:Health Services Accessibility; D006801:Humans; D014481:United States
chemical_list: D019380:Anti-HIV Agents